Which perinatal finding is most likely associated with a FHR tracing showing fetal growth restriction?

Which perinatal finding is most likely associated with a FHR tracing showing fetal growth restriction?

• A. Maternal gestational diabetes, well-controlled with diet
• B. Maternal cholestasis of pregnancy
• C. Fetal growth restriction
• D. Gestational age 38 weeks

Answer: (C)

A fetal heart rate (FHR) tracing that indicates fetal growth restriction typically reflects underlying issues with fetal development, and the presence of fetal growth restriction itself is the most direct and relevant finding associated with an abnormal FHR tracing. This condition, known medically as intrauterine growth restriction (IUGR), often correlates with compromised placental function or other physiological stressors that can negatively affect the fetus. When fetal growth is restricted, it may lead to changes in the FHR pattern, such as decreased variability and the presence of decelerations, which signal that the fetus may be dealing with hypoxia or other forms of distress. Therefore, identifying fetal growth restriction on an FHR tracing directly correlates with the findings observed when assessing fetal health. Other options are less direct in their association with FHR abnormalities. For instance, maternal gestational diabetes, when well-controlled, typically does not contribute to FHR abnormalities as significantly as direct fetal condition markers such as growth restriction. Similarly, while maternal cholestasis can impact fetal outcomes, it's more often linked to other complications rather than providing a concrete positive indicator of FHR abnormalities when assessing for growth restriction. The option regarding gestational age, while relevant for other conditions, does not specifically explain potential F

A fetal heart rate (FHR) tracing that indicates fetal growth restriction typically reflects underlying issues with fetal development, and the presence of fetal growth restriction itself is the most direct and relevant finding associated with an abnormal FHR tracing. This condition, known medically as intrauterine growth restriction (IUGR), often correlates with compromised placental function or other physiological stressors that can negatively affect the fetus.

When fetal growth is restricted, it may lead to changes in the FHR pattern, such as decreased variability and the presence of decelerations, which signal that the fetus may be dealing with hypoxia or other forms of distress. Therefore, identifying fetal growth restriction on an FHR tracing directly correlates with the findings observed when assessing fetal health.

Other options are less direct in their association with FHR abnormalities. For instance, maternal gestational diabetes, when well-controlled, typically does not contribute to FHR abnormalities as significantly as direct fetal condition markers such as growth restriction. Similarly, while maternal cholestasis can impact fetal outcomes, it's more often linked to other complications rather than providing a concrete positive indicator of FHR abnormalities when assessing for growth restriction. The option regarding gestational age, while relevant for other conditions, does not specifically explain potential F